Search

Streamlining ENT pathways

Laryngopharyngeal reflux (LPR) may present with severe extra-gastrointestinal symptoms – including a persistent cough, vocal problems, asthma or difficulty swallowing – that can be incorrectly attributed to ENT problems because patients and GPs alike assume they stem from colds, allergies or over-using the voice.

Neuromod establishes global leadership team following launch of Lenire in Spain

Neuromod Devices has announced the formation of a global commercial leadership team to further commercialise its Lenire tinnitus treatment device through key partnerships.

Neuromod publishes results of second large-scale clinical trial for tinnitus, shows greater improvement of symptoms

Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.

Hearing Care Centre Ipswich relocates to new state-of-the-art clinic

Audiology & aural care experts at the Hearing Care Centre expand operations in Ipswich with the relocation of their flagship clinic.

KARL STORZ Strengthens its ENT Portfolio with the Acquisition of AventaMed in Ireland

The family-owned medical technology company KARL STORZ announces the acquisition of 100 percent of the shares of AventaMed DAC, an Irish medical technologies company.